Connor, Clark & Lunn Investment Management »

Compass Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $477k 241k 1.98
2023-12-31 $332k 213k 1.56
2023-09-30 $262k 133k 1.97
2023-06-30 $366k 115k 3.18
2023-03-31 $74k 23k 3.27